小RNA
发病机制
生物
神经科学
阿尔茨海默病
疾病
神经学
医学
病理
基因
遗传学
作者
Tania Arora,Vikash Prashar,Randeep Singh,Tushar Singh Barwal,Harish Changotra,Arti Sharma,Jyoti Parkash
标识
DOI:10.1007/s12035-022-02950-z
摘要
Alzheimer’s disease (AD) is a progressive degeneration of neurons due to the accumulation of amyloid-β peptide (Aβ) and hyper-phosphorylation of tau protein in the neuronal milieu leading to increased oxidative stress and apoptosis. Numerous factors contribute towards the progression of AD, including miRNA, which are 22–24 nucleotides long sequence which acts as critical regulators of cellular processes by binding to 3′ UTR of mRNA, regulating its expression post-transcriptionally. This review aims to determine the miRNA with the most significant dysregulation in the brain and cerebrospinal fluid (CSF) of human patients. A systemized inclusion/exclusion criterion has been utilized based on selected keywords followed by screening of those articles to conclude a list of 8 highly dysregulated miRNAs based on the fold change of AD vs control patients, which could be used in clinical testing as these miRNAs play central role in the pathophysiology of AD. Furthermore, a network study of highly dysregulated miRNA estimated the association of these miRNA in the mediation of Aβ generation and aggregation, inhibition of autophagy, reduction of Aβ clearance, microglial and astrocytic activation, neuro-inflammation, tau hyper-phosphorylation, and synaptic loss.
科研通智能强力驱动
Strongly Powered by AbleSci AI